シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - pathology - agilent’s immunohistochemistry (ihc) reagents are intended to be used to identify, by immunological techniques, antigens in tissues or cytologic specimens, and are used after the primary diagnosis.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - immunology - agilent’s immunohistochemistry (ihc) reagents are intended to be used to identify, by immunological techniques, antigens in tissues or cytologic specimens, and are used after the primary diagnosis.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - immunology - agilent’s immunohistochemistry (ihc) reagents are intended to be used to identify, by immunological techniques, antigens in tissues or cytologic specimens, and are used after the primary diagnosis.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - immunology - agilent’s immunohistochemistry reagents are intended to be used to identify antigens in tissues or cytologic specimens and are used after the primary diagnosis, and for use in identification of immune disorders.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - immunology - agilent’s immunohistochemistry reagents are intended to be used to identify antigens in tissues or cytologic specimens and are used after the primary diagnosis, and for use in diagnosis/staging/characterization of cancers other than haematologic-based cancers.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - hematology - agilent’s immunohistochemistry reagents are intended to be used to identify antigens in tissues or cytologic specimens and are used after the primary diagnosis, and for use in diagnosis/staging/characterization of blood cancers, or detection of other haematology markers.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - pathology - agilent’s immunohistochemistry reagents are intended to be used to identify antigens in tissues or cytologic specimens and are used after the primary diagnosis, and for use in diagnosis/staging/characterization of cancers other than haematologic-based cancers, or detection of other cancer makers.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - hematology - agilent’s multimix™ immunochemistry reagents are intended to be used to identify, by flow cytometry, antigens in or cytologic specimens and are used after the primary diagnosis, and for use in diagnosis/staging/characterization of blood cancers, or detection of other haematology markers.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - hematology - agilent’s multimix™ immunochemistry reagents are intended to be used to identify, by flow cytometry, antigens in cytologic specimens and are used after the primary diagnosis, and for use in diagnosis/staging/characterization of blood cancers, or detection of other haematology markers.

シンガポール - 英語 - HSA (Health Sciences Authority)

agilent technologies singapore (international) pte ltd - immunology - for in vitro diagnostic use. monoclonal mouse anti-cytomegalovirus, clones cch2 + ddg9, is intended for use in immunohistochemistry. the antibody labels human cytomegalovirus (hcmv)-infected cells and is a useful aid in the identification of hcmv infection in human tissues. the clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist.